Alkermes Inspiration Grants®

Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive needs of those most impacted by serious diseases in our therapeutic areas of focus. Applicants and grant recipients include a broad variety of organizations, from large advocacy groups and academic institutions to small, grassroots organizations in rural communities – all working to make a difference. The large volume of high-quality submissions received each time this program opens for applications reinforces the need for funding to support impactful, community-based programs.

Learn more

Videos from this campaign

On a blue background "Alkermes Pathways Research Awards"
Alkermes is pleased to announce the 2023 recipients of grants from the Alkermes Inspiration Grants program
two people talking closely

Content from this campaign

Philanthropy & Cause Initiatives

Alkermes Announces Launch of 6th Annual Alkermes Pathways Research Awards® Program
Alkermes plc (Nasdaq: ALKS) announced that it will begin accepting applications for its annual Alkermes Pathways Research Awards® program on Friday, Sept. 15, 2023.

Philanthropy & Cause Initiatives

Alkermes Announces Recipients of 2023 Alkermes Inspiration Grants® Program
Alkermes plc (Nasdaq: ALKS) today announced the recipients of the 2023 Alkermes Inspiration Grants® program. Grants were awarded to 11 nonprofit organizations working to address the needs of people living with addiction, serious mental illness or cancer.

Health & Healthcare

The Impact of Alkermes Inspiration Grants
In 2021, the Alkermes Inspiration Grants program funded nonprofit programs providing support for patient communities in the areas of addiction, serious mental illness and cancer. Watch this video to hear grantees’ perspectives about the impact of AIG.

Health & Healthcare

Alkermes Inspiration Grants Now Open for Applications
The 2023 Alkermes Inspiration Grants® program is now open for applications!

Health & Healthcare

Alkermes Announces Application Period for 2023 Alkermes Inspiration Grants® Program To Support Innovative Initiatives Focused on People Affected by Addiction, Serious Mental Illness or Cancer
Alkermes plc (Nasdaq: ALKS) recently announced that the company will accept applications for its Alkermes Inspiration Grants® program beginning on May 1, 2023.

Awards, Ratings & Rankings

Alkermes Announces Recipients of 2022 Alkermes Inspiration Grants® Program
Alkermes plc (Nasdaq: ALKS) announced the 2022 recipients of the Alkermes Inspiration Grants® program.

Philanthropy & Cause Initiatives

About the Alkermes Inspiration Grants® Program
Organizations supporting people living with addiction, serious mental illness and cancer have faced unique needs and challenges during the COVID pandemic.

Philanthropy & Cause Initiatives

Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer
Alkermes plc (Nasdaq: ALKS) announced that the company will accept applications for its Alkermes Inspiration Grants® program beginning on June 15, 2022.

Philanthropy & Cause Initiatives

Alkermes Announces Recipients of 2021 Alkermes Inspiration Grants® Program
Grants were awarded to 11 nonprofits working to address the needs of people living with addiction, serious mental illness or cancer, including programs serving historically under-resourced or underrepresented communities.

Philanthropy & Cause Initiatives

Alkermes Inspiration Grants® 2021 Applications Are Now Open
This year’s Alkermes Inspiration Grants® is now officially open for applications! We look forward to reviewing proposals for innovative nonprofit programs to address #addiction, serious mental illness or cancer.
Alkermes logo

More from Alkermes

  1. Alkermes: Corporate Responsibility
    We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

  2. Alkermes: Diversity, Inclusion & Belonging
    Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

  3. Alkermes Medicines & Focus: Serious Mental Illness
    We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

  4. Alkermes Medicines & Focus: Cancer
    We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

  5. Alkermes Inspiration Grants®
    Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

  6. Alkermes Medicines & Focus: Addiction
    We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...